PT-141

Description

PT-141 (Bremelanotide) is a melanocortin receptor agonist derived from MT2. Enhances sexual desire via central nervous system pathways rather than vascular effects. FDA-approved (as bremelanotide) for hypoactive sexual desire disorder in premenopausal women.

Additional Information:
Dose: 10 mg
Third- party tested
Made in Canada 

Endorsed by Dr Sanjeev Goel – Canada’s Longevity MD.  We believe in providing the highest quality peptides backed by science.